QIM
ABMD

Quantitative Investment Management’s Abiomed Inc ABMD Stock Holding History

Quantitative Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,052
Closed -$2.95M – 493
2021
Q3 		$2.95M Buy
+9,052
New +$3.07M 0.27% 80
2021
Q2 		– Sell
-8,388
Closed -$2.67M – 632
2021
Q1 		$2.67M Sell
8,388
-3,035
-27% -$971K 0.23% 117
2020
Q4 		$3.7M Sell
11,423
-1,457
-11% -$403K 0.3% 76
2020
Q3 		$3.57M Buy
12,880
+10,063
+357% +$2.9M 0.31% 62
2020
Q2 		$680K Buy
+2,817
New +$566K 0.07% 277
2020
Q1 		– Sell
-29,063
Closed -$4.96M – 878
2019
Q4 		$4.96M Buy
29,063
+10,621
+58% +$1.97M 0.15% 162
2019
Q3 		$3.28M Buy
18,442
+17,047
+1,222% +$3.68M 0.18% 164
2019
Q2 		$363K Buy
+1,395
New +$370K 0.01% 546
2018
Q2 		– Sell
-12,600
Closed -$3.67M – 973
2018
Q1 		$3.67M Sell
12,600
-2,100
-14% -$532K 0.06% 336
2017
Q4 		$2.75M Sell
14,700
-1,600
-10% -$299K 0.04% 438
2017
Q3 		$2.75M Sell
16,300
-33,900
-68% -$5.13M 0.03% 441
2017
Q2 		$7.19M Sell
50,200
-23,000
-31% -$3.09M 0.11% 241
2017
Q1 		$9.16M Buy
73,200
+61,800
+542% +$7.16M 0.14% 201
2016
Q4 		$1.28M Buy
11,400
+2,300
+25% +$266K 0.03% 570
2016
Q3 		$1.17M Sell
9,100
-10,800
-54% -$1.29M 0.04% 421
2016
Q2 		$2.17M Sell
19,900
-30,400
-60% -$3.02M 0.1% 279
2016
Q1 		$4.77M Buy
50,300
+45,900
+1,043% +$3.87M 0.23% 105
2015
Q4 		$397K Buy
+4,400
New +$373K 0.02% 543

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Quantitative Investment Management's ABMD Position: Q4 2021 in Review

Quantitative Investment Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 9,052 shares — an estimated $2.95M sold.

Quantitative Investment Management first reported a position in ABMD in Q4 2015 and held it in 18 quarters. The position peaked at $9.16M in Q1 2017. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Quantitative Investment Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 9,052 Abiomed Inc shares in Q4 2021, an estimated $2.95M.
  • Quantitative Investment Management first reported a position in Abiomed Inc in Q4 2015 and held it in 18 quarters.
  • Quantitative Investment Management's Abiomed Inc position peaked at $9.16M in Q1 2017.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Quantitative Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.